Literature DB >> 8420271

Graded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasia.

S C Kadakia1, R K Wong.   

Abstract

Pneumatic dilation is the initial therapy for primary esophageal achalasia. Recently, polyethylene balloon (Rigiflex) dilators have been used with varying success and complication rate. We performed a total of 47 dilations in 29 consecutive patients with achalasia using the Rigiflex dilators. The 3.0-cm balloon was always used first. If there was no symptomatic response, a 3.5-cm balloon was used after 4-8 wk. If there was still no symptomatic response after 4-8 wk, a 4.0-cm dilator was used. Eighteen (62%) patients were successfully dilated with a 3.0-cm balloon only. Of 11 patients not responding to a 3.0-cm balloon, five were dilated successfully with a 3.5-cm balloon. Of six patients not responding to a 3.5-cm balloon, four were successfully dilated with a 4.0-cm balloon dilator. Two patients eventually required surgery. The overall success with Rigiflex balloon dilator was achieved in 27 of 29 (93%) patients. There were no complications. We conclude that pneumatic dilation for esophageal achalasia performed in a graded fashion starting with Rigiflex 3.0-cm balloon dilator has a high success rate without complications in patients with achalasia.

Entities:  

Mesh:

Year:  1993        PMID: 8420271

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  41 in total

1.  Does illness severity matter? A comparison of laparoscopic esophagomyotomy with fundoplication and esophageal dilation for achalasia.

Authors:  Jason F Reynoso; Manish M Tiwari; Albert W Tsang; Dmitry Oleynikov
Journal:  Surg Endosc       Date:  2010-10-26       Impact factor: 4.584

2.  Selection and evaluation of three interventional procedures for achalasia based on long-term follow-up.

Authors:  Ying-Sheng Cheng; Ming-Hua Li; Wei-Xiong Chen; Ni-Wei Chen; Qi-Xin Zhuang; Ke-Zhong Shang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

3.  Guidelines on the use of oesophageal dilatation in clinical practice.

Authors:  S A Riley; S E A Attwood
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

4.  Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial.

Authors:  M F Vaezi; J E Richter; C M Wilcox; P L Schroeder; S Birgisson; R L Slaughter; R E Koehler; M E Baker
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

5.  Fluoroscopically guided balloon dilation of the esophagus.

Authors:  Kevin J Blount; Drew L Lambert; Hubert A Shaffer; Eduard E de Lange
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

6.  Treatment of esophageal motility disorders based on the chicago classification.

Authors:  Carla Maradey-Romero; Scott Gabbard; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2014-12

7.  Long-term results of graded pneumatic dilatation under endoscopic guidance in patients with primary esophageal achalasia.

Authors:  Ahmet Dobrucali; Yusuf Erzin; Murat Tuncer; Ahmet Dirican
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

8.  Pneumatic dilation for achalasia: late results of a prospective follow up investigation.

Authors:  V F Eckardt; I Gockel; G Bernhard
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  Achalasia - an update.

Authors:  Joel E Richter
Journal:  J Neurogastroenterol Motil       Date:  2010-07-27       Impact factor: 4.924

10.  The cost-effectiveness of treatment strategies for achalasia.

Authors:  J Barry O'Connor; Mendel E Singer; Thomas F Imperiale; Michael F Vaezi; Joel E Richter
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.